Literature DB >> 23519361

[Early postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer. Long-term results of the EORTC trial 22911].

M Ehmann1, F Wenz.   

Abstract

Entities:  

Year:  2013        PMID： 23519361     DOI： 10.1007/s00066-013-0333-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  7 in total

Review 1.  Luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength.

Authors:  Michael B Williams; Javier Hernandez; Ian Thompson
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

2.  Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911).

Authors:  Michel Bolla; Hein van Poppel; Bertrand Tombal; Kris Vekemans; Luigi Da Pozzo; Theo M de Reijke; Antony Verbaeys; Jean-François Bosset; Roland van Velthoven; Marc Colombel; Cees van de Beek; Paul Verhagen; Alphonsus van den Bergh; Cora Sternberg; Thomas Gasser; Geertjan van Tienhoven; Pierre Scalliet; Karin Haustermans; Laurence Collette
Journal:  Lancet       Date:  2012-10-19       Impact factor: 79.321

3.  Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911).

Authors:  Michel Bolla; Hein van Poppel; Laurence Collette; Paul van Cangh; Kris Vekemans; Luigi Da Pozzo; Theo M de Reijke; Antony Verbaeys; Jean-François Bosset; Roland van Velthoven; Jean-Marie Maréchal; Pierre Scalliet; Karin Haustermans; Marianne Piérart
Journal:  Lancet       Date:  2005 Aug 13-19       Impact factor: 79.321

4.  Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study.

Authors:  Alessandra Siegmann; Dirk Bottke; Julia Faehndrich; Gunnar Lohm; Kurt Miller; Detlef Bartkowiak; Thomas Wiegel; Wolfgang Hinkelbein
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

5.  Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.

Authors:  Thomas Wiegel; Dirk Bottke; Ursula Steiner; Alessandra Siegmann; Reinhard Golz; Stephan Störkel; Norman Willich; Axel Semjonow; Rainer Souchon; Michael Stöckle; Christian Rübe; Lothar Weissbach; Peter Althaus; Udo Rebmann; Tilman Kälble; Horst Jürgen Feldmann; Manfred Wirth; Axel Hinke; Wolfgang Hinkelbein; Kurt Miller
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

6.  Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients.

Authors:  Piet Ost; Valérie Fonteyne; Geert Villeirs; Nicolaas Lumen; Willem Oosterlinck; Gert De Meerleer
Journal:  Eur Urol       Date:  2009-05-29       Impact factor: 20.096

7.  Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

Authors:  Andrew J Stephenson; Peter T Scardino; Michael W Kattan; Thomas M Pisansky; Kevin M Slawin; Eric A Klein; Mitchell S Anscher; Jeff M Michalski; Howard M Sandler; Daniel W Lin; Jeffrey D Forman; Michael J Zelefsky; Larry L Kestin; Claus G Roehrborn; Charles N Catton; Theodore L DeWeese; Stanley L Liauw; Richard K Valicenti; Deborah A Kuban; Alan Pollack
Journal:  J Clin Oncol       Date:  2007-05-20       Impact factor: 44.544
  7 in total
  3 in total

1.  Risk of biochemical recurrence and timing of radiotherapy in pT3a N0 prostate cancer with positive surgical margin : A single center experience.

Authors:  Nina-Sophie Hegemann; Sebastian Morcinek; Alexander Buchner; Alexander Karl; Christian Stief; Ruth Knüchel; Stefanie Corradini; Minglun Li; Claus Belka; Ute Ganswindt
Journal:  Strahlenther Onkol       Date:  2016-06-06       Impact factor: 3.621

Review 2.  [Salvage lymphadenectomy in patients with prostate cancer recurrence: A review].

Authors:  D K Osmonov; A V Aksenov; C A Jilg; W Schultze-Seeman; C M Naumann; M F Hamann; K Bothe; K-P Jünemann
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

3.  Effect of Salvage Radiotherapy and Endocrine Therapy on Patients with Biochemical Recurrence After Prostate Cancer Operation- a Meta‑Analysis.

Authors:  Yong Yuan; Qiang Zhang; Chaofan Xie; Tao Wu
Journal:  Am J Mens Health       Date:  2021 May-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.